David Spriggs, MD, PhD, was the Head of the Division of Sloan Tumor Oncology for more than 10 years At Memorial Sloan Kettering (MSK). He and the Associate Cancer Center Director for Clinical and Translational Research. He is a Fellow of the American Society of Clinical Oncology and the American College of Physicians. Dr Spriggs has concentrated on the management of Gynecologic Malignancies for nearly 30 years. He leads a research laboratory developing new drug targets for CA125 / MUC16 on the surface of Ovarian and Endometrial cancer. In addition, he has served in multiple capacities for the American Society of Clinical Oncology (ASCO), the American Society of Cancer Research (AACR), The National Cancer Center Network (NCCN) and the National Cancer Center (NCI).